100 related articles for article (PubMed ID: 6504966)
1. Effects of multiple doxorubicin doses on mouse cardiac and hepatic catalase.
D'Alessandro N; Candiloro V; Crescimanno M; Flandina C; Dusonchet L; Crosta L; Rausa L
Pharmacol Res Commun; 1984 Feb; 16(2):145-51. PubMed ID: 6504966
[TBL] [Abstract][Full Text] [Related]
2. Effects of doxorubicin on mouse heart catalase.
D'Alessandro N; Nicotra C; Crescimanno M; Rausa L
Drugs Exp Clin Res; 1987; 13(10):601-6. PubMed ID: 3428124
[TBL] [Abstract][Full Text] [Related]
3. Morphological changes and catalase activity in the hearts of CD 1 mice following acute starvation or single doses of doxorubicin, epirubicin or mitoxantrone.
Crescimanno M; Flandina C; Rausa L; Sanguedolce R; D'Alessandro N
Chemioterapia; 1988 Feb; 7(1):53-9. PubMed ID: 3163942
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of doxorubicin chronic toxicity in catalase-overexpressing transgenic mouse hearts.
Kang YJ; Sun X; Chen Y; Zhou Z
Chem Res Toxicol; 2002 Jan; 15(1):1-6. PubMed ID: 11800590
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin.
Doroshow JH; Locker GY; Myers CE
J Clin Invest; 1980 Jan; 65(1):128-35. PubMed ID: 7350193
[TBL] [Abstract][Full Text] [Related]
6. Effect of exercise training on antioxidant enzymes and cardiotoxicity of doxorubicin.
Kanter MM; Hamlin RL; Unverferth DV; Davis HW; Merola AJ
J Appl Physiol (1985); 1985 Oct; 59(4):1298-303. PubMed ID: 4055607
[TBL] [Abstract][Full Text] [Related]
7. Effect of adriamycin on the activities of superoxide dismutase, glutathione peroxidase and catalase in tissues of mice.
Sazuka Y; Tanizawa H; Takino Y
Jpn J Cancer Res; 1989 Jan; 80(1):89-94. PubMed ID: 2496064
[TBL] [Abstract][Full Text] [Related]
8. The chemical inducibility of mouse cardiac antioxidants and phase 2 enzymes in vivo.
Cao Z; Li Y
Biochem Biophys Res Commun; 2004 May; 317(4):1080-8. PubMed ID: 15094379
[TBL] [Abstract][Full Text] [Related]
9. Modulatory effects of meloxicam on cardiotoxicity and antitumor activity of doxorubicin in mice.
Hassan MH; El-Beshbishy HA; Aly H; Attia SM; Bahashwan SA; Ghobara MM
Cancer Chemother Pharmacol; 2014 Sep; 74(3):559-69. PubMed ID: 25053391
[TBL] [Abstract][Full Text] [Related]
10. Role of (+-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) in modulating free radical scavenging enzymes in doxorubicin-induced cardiomyopathy.
Alderton P; Gross J; Green MD
Cancer Res; 1990 Aug; 50(16):5136-42. PubMed ID: 2116226
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of malondialdehyde in mouse heart following acute dosing with adriamycin is strain specific and unaffected by cardiac catalase status.
Baird MB; Hough JL; Sfeir GT
Res Commun Chem Pathol Pharmacol; 1993 Jun; 80(3):363-6. PubMed ID: 8351415
[TBL] [Abstract][Full Text] [Related]
12. The effect of doxorubicin on hepatic and cardiac glutathione.
Doroshow JH; Locker GY; Baldinger J; Myers CE
Res Commun Chem Pathol Pharmacol; 1979 Nov; 26(2):285-95. PubMed ID: 574979
[TBL] [Abstract][Full Text] [Related]
13. [The effect of superoxide dismutase and catalase on the delayed toxicity of doxorubicin].
Villani F; Galimberti M; Poggi P; Rozza A; Lanza E; Favalli L; Scavini C
Cardiologia; 1992 Oct; 37(10):709-11. PubMed ID: 1296877
[TBL] [Abstract][Full Text] [Related]
14. In vivo effects of doxorubicin and isoproterenol on reduced glutathione and H2O2 production in mouse heart.
D'Alessandro N; Rausa L; Crescimanno M
Res Commun Chem Pathol Pharmacol; 1988 Oct; 62(1):19-30. PubMed ID: 3205977
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic administration of doxorubicin on cardiac adenylate cyclase activity in mice.
Robison TW; Giri SN
Biochem Biophys Res Commun; 1986 Apr; 136(2):745-52. PubMed ID: 3707589
[TBL] [Abstract][Full Text] [Related]
16. Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine.
Doroshow JH; Locker GY; Ifrim I; Myers CE
J Clin Invest; 1981 Oct; 68(4):1053-64. PubMed ID: 7287901
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity.
Kang YJ; Chen Y; Yu A; Voss-McCowan M; Epstein PN
J Clin Invest; 1997 Sep; 100(6):1501-6. PubMed ID: 9294117
[TBL] [Abstract][Full Text] [Related]
18. Recombinant adenovirus-mediated cardiac gene transfer of superoxide dismutase and catalase attenuates postischemic contractile dysfunction.
Woo YJ; Zhang JC; Vijayasarathy C; Zwacka RM; Englehardt JF; Gardner TJ; Sweeney HL
Circulation; 1998 Nov; 98(19 Suppl):II255-60; discussion II260-1. PubMed ID: 9852911
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of cardiac cyclic nucleotide phosphodiesterases by doxorubicin and daunorubicin.
Law J; Fumagalli A; Schein PS; Rahman A
Life Sci; 1985 Feb; 36(6):589-99. PubMed ID: 2982070
[TBL] [Abstract][Full Text] [Related]
20. [Organ-specific antitoxic effects of N-stearoylethanolamine in male mice with Lewis carcinoma under doxorubicin intoxication].
Hudz' IeA; Hula NM; Horid'ko TM; Bashta IuM; Voieĭkov AI
Ukr Biokhim Zh (1999); 2013; 85(2):45-51. PubMed ID: 23808309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
